1 completed, 1 not yet recruiting, 1 unknown. 3 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 1, Not yet recruiting 1, Unknown 1 |
Follow Newly Diagnosed: new trials by email Literature Review of Newly Diagnosed trials Research Report on Newly Diagnosed
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Anti-BCMA CAR-T Therapy in Newly Diagnosed Myeloma Patients Who Are Transplant-ineligible CAR-T - Multiple Myeloma, Newly Diagnosed | Not applicable | Not yet recruiting | Xuzhou Medical University | 35 | 2025-07-15 | 2025-07-17 |
| Shared Decision Making on Care Pathways and CAMs: A Pilot Study alternative medicine education consultation - Breast Cancer, Non-metastatic | Not applicable | Unknown | University Hospital, Grenoble | 100 | 2022-09-28 | 2023-05-16 |
| Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients exenatide injection, Mixed Protamine Zinc Recombinant Human Insulin Lispro 25R, Pioglitazone - Diabetes Mellitus, Type 2, Newly Diagnosed | Not applicable | Completed | Sun Yat-sen University | 416 | 2010-08-01 | 2013-08-21 |
Breast Neoplasms (1) · Diabetes Mellitus, Type 2 (1) · Multiple Myeloma (1)
Neoplasms (2) · Blood Protein Disorders (1) · Breast Diseases (1) · Cardiovascular Diseases (1) · Diabetes Mellitus (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemorrhagic Disorders (1) · Hemostatic Disorders (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphoproliferative Disorders (1) · Metabolic Diseases (1)
Commerce (1) · Exenatide (1) · Pioglitazone (1)
Sun Yat-sen University (1) · University Hospital, Grenoble (1) · Xuzhou Medical University (1)
China (1) · France (1)
Jianping Weng, Doctor (1) · Kailin Xu (1)